Welcome to LookChem.com Sign In|Join Free
  • or
2-[(4-phenylpiperazin-1-yl)methyl]quinazolin-4(1H)-one is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

19062-53-4

Post Buying Request

19062-53-4 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

19062-53-4 Usage

Structure

Quinazoline derivative containing a piperazine ring and a phenyl group

Pharmacological activities

Potential for treating various disorders

Disorder treatment

Psychiatric and neurological conditions

Receptor system interaction

May act as a ligand for different receptor systems in the central nervous system

Receptor potential interactions

Serotonin and dopamine receptors

Research status

Further research needed to understand its potential medical applications

Check Digit Verification of cas no

The CAS Registry Mumber 19062-53-4 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,9,0,6 and 2 respectively; the second part has 2 digits, 5 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 19062-53:
(7*1)+(6*9)+(5*0)+(4*6)+(3*2)+(2*5)+(1*3)=104
104 % 10 = 4
So 19062-53-4 is a valid CAS Registry Number.

19062-53-4SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name 2-[(4-phenylpiperazin-1-yl)methyl]-1H-quinazolin-4-one

1.2 Other means of identification

Product number -
Other names 2-[(4-phenylpiperazin-1-yl)methyl]quinazolin-4(1H)-one

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:19062-53-4 SDS

19062-53-4Downstream Products

19062-53-4Relevant academic research and scientific papers

Molecular modeling study and synthesis of quinazolinone-arylpiperazine derivatives as α1-adrenoreceptor antagonists

Abou-Seri, Sahar Mahmoud,Abouzid, Khaled,Abou El Ella, Dalal A.

, p. 647 - 658 (2011/03/22)

Three series of new 2-[(4-substituted piperazin-1-yl) methyl]quinazolin- 4(3H)-ones 4a-c, Ethyl 6,7-dimethoxy-4-oxo-3-[2-(4-substituted piperazin-1-yl)acetamido/propanamido]-3,4-dihydroquinazoline-2-carboxylates 9a-f and their 2-methyl analogues 13a-l were designed and synthesized as promising α1-adrenoceptor antagonists. The final compounds were evaluated for their in vivo hypotensive activity in normotensive cats. The most potent hypotensive quinazolinone derivatives 4b, 9e, 13i, 13j were further tested on isolated thoracic aortic rings of male Wister rats. All the tested compounds displayed α1-blocking activity with IC50 ranging from 0.2 to 0.4 mM less than prazosin. Furthermore, in the present work, molecular modeling study using Accelrys Discovery Studio 2.1 software was performed by mapping the synthesized compounds to the α1- adrenoceptor antagonist hypothesis in order to predict their mechanism of action. Compound 13j which has the best-fitting score displayed the highest in vivo and in vitro activity among the tested compounds.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 19062-53-4